Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The GRRAND-F trial has been given the green light and is now open to recruitment.

GRRAND-F logo

THE GRRAND-F study has opened to recruitment today (09 January 2020) at the Oxford University Hospital NHS Foundation Trust.

GRRAND-F is a feasibility study to see whether a rehabilitation programme (including physiotherapy sessions, advice for managing pain and coping with fatigue and other common side-effects) is acceptable for patients who have been discharged from hospital following head and neck cancer surgery.

This study will be recruiting 60 participants from 4 NHS sites across England. Following surgery participants will be randomised to receive either standard care including in-patient physiotherapy and an advice leaflet detailing basic exercise and self-care following surgery advice or to also receive up to 6 physiotherapy appoints over a 6 month period.

The study will be investigating the acceptability of the study intervention to patients invited to join the study, study compliance, completion of study paperwork, continuation of the rehabilitation programme at home and the need for further treatment following the initial surgery. A number of participants and physiotherapists delivering the study will also be interviewed to explore any changes required to further improve the programme.

Results from the study will help inform whether a large multi-centre definitive randomised controlled trial should be undertaken.

Similar stories

Going straight to surgery found to be better than undergoing rehabilitation first for longstanding anterior cruciate ligament injury

New research, funded by the National Institute for Health and Care Research (NIHR), shows initial surgery to be more successful and cost effective than undergoing treatment with rehabilitation first to treat longstanding anterior cruciate ligament injury.

Oxford receives NIHR funding to test anti-TNF on post operative delirium

Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.

Emergency departments to use the FORCE pathway for wrist fractures in children

New research from the University of Oxford has shown that doctors can simplify treatment for the most common fracture in children, reducing NHS costs.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.